In other cardiovascular disorders such as atherosclerosis, activating CB2 was also reported to be protective through the inhibition of inflammatory reaction and lipid metabolism in plaque macrophages (Jiang et al., 2016; Maslov and Karpov, 2017). This evidence concerns the gene CNR2 and cardiovascular disorder.